FILANA THERAPEUTICS, INC. (FLNA) › Operating IncomeFILANA THERAPEUTICS, INC. (FLNA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$6.75M2010: -$13.70M2011: -$3.51M2012: -$3.90M2013: $31.36M2014: -$12.43M2015: -$14.20M2016: -$14.96M2017: -$11.95M2018: -$6.66M2019: -$4.96M2020: -$6.45M2021: -$32.87M2022: -$80.02M2023: -$105.96M2024: -$141.45M2025: -$95.39M-$95.39M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$95.39M+32.6%2024-$141.45M-33.5%2023-$105.96M-32.4%2022-$80.02M-143.5%2021-$32.87M-409.9%2020-$6.45M-30.0%2019-$4.96M+25.6%2018-$6.66M+44.2%2017-$11.95M+20.1%2016-$14.96M-5.3%2015-$14.20M-14.2%2014-$12.43M-139.6%2013$31.36M+904.8%2012-$3.90M-10.9%2011-$3.51M+74.4%2010-$13.70M-102.9%2009-$6.75M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share